Medically integrated pharmacy (MIP) is moving beyond its roots in oncology and emerging as a significant growth opportunity across specialty care. By embedding pharmacy services directly within physician practices and health systems, the model brings prescribing, dispensing, financial counseling, adherence monitoring, and clinical management together at the point of care—while creating new, durable revenue streams.
In this perspective, CWH Advisors examines the growth of MIP and in-office specialty dispensing, including the expansion into rheumatology, gastroenterology, neurology, and urology; the financial outlook for specialty pharmacy platforms; and the implications for private equity investors, health systems, physician groups, and home infusion providers.
Please complete the form to receive this white paper. Upon submission, the white paper will be sent to your inbox.
Perspective Papers 
Insights 
Webinars 